Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Despite the improvements in dialysis technology, the cardiovascular mortality rate is still unacceptably high among dialysis patients. It is obvious that traditional risk factors, such as hypertension, chronic heart failure (CHF), dyslipidemia and diabetes mellitus, may account for a large part of the increased cardiovascular mortality rate in these patients. However, based on recent research it could be speculated that other, non-traditional risk factors might also contribute to the high cardiovascular mortality rate in dialysis patients. Chronic inflammation, as evidenced by increased levels of pro-inflammatory cytokines and C-reactive protein (CRP), is a common feature in dialysis patients and is associated with an increased cardiovascular morbidity and mortality. Indeed, elevated levels of pro-inflammatory cytokines (such as TNF-α, IL-1 and IL-6) may cause malnutrition and progressive atherosclerotic cardiovascular disease by several pathogenetic mechanisms, which will be discussed in this review. Based on the strong associations observed between malnutrition, inflammation and atherosclerosis in patients with chronic renal failure (CRF) we have proposed that these features constitute a specific syndrome (MIA), which carries a high mortality rate. As elevated levels of pro-inflammatory cytokines may play a central part in the vicious circle of malnutrition, inflammation and atherosclerosis, further research is needed to investigate whether or not different anti-cytokine treatment strategies may improve survival in dialysis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, T. B., Ferrucci, L., Tracy, R. P., Corti, M. C., Wacholder, S., Ettinger, W. H., Heimovitz, H., Cohen, H. J., & Wallace, R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00066-2 · Cited by 1,488
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., Flier, J. S., Lowell, B. B., Fraker, D. L., & Alexander, H. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.171 · Cited by 791
Munger, M. A., Johnson, B., Amber, I. J., Callahan, K. S., & Gilbert, E. M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89206-5 · Cited by 237
Cited by
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179
“INFLAMMATION AND OXIDATIVE STRESS Inflammation is a common feature of ESRD and it has been recognized that about 30 to 50% of predialysis, hemodialysis (HD), and peritoneal dialysis (PD) patients have serologic evidence of an activated inflammatory respons”
BackgroundSelf-citationAspects of Immune Dysfunction in End-stage Renal Disease
Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., Tranaeus, A., Stenvinkel, P., & Lindholm, B. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00950208 · Cited by 1,087
Self-citationOberg, B. P., McMenamin, E., Lucas, F. L., McMonagle, E., Morrow, J., Ikizler, T. A. L. P., & Himmelfarb, J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00465.x · Cited by 781
C-Reactive Protein Levels Correlate With Mortality and Organ Failure in Critically Ill Patientsa
Lobo, S. M. A., Lobo, F. R. M., Bota, D. P., Lopes-Ferreira, F., Soliman, H. M., Meélot, C., & Vincent, J.-L. (2003) · Chest · doi:10.1378/chest.123.6.2043 · Cited by 448
Review Articles: Inflammation in End‐stage Renal Disease: Sources, Consequences, and Therapy
Stenvinkel, P., & Alvestrand, A. (2002) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2002.00083.x · Cited by 425
Self-citationPsychosocial Aspects of Chronic Disease: ESRD as a Paradigmatic Illness
Cukor, D., Cohen, S. D., Peterson, R. A., & Kimmel, P. L. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030345 · Cited by 385
Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
Stenvinkel, P. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02269.x · Cited by 332
Self-citationSepticemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
Ishani, A., Collins, A. J., Herzog, C. A., & Foley, R. N. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00414.x · Cited by 313
Schepers, E., Meert, N., Glorieux, G., Goeman, J., Van der Eycken, J., & Vanholder, R. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl584 · Cited by 296
Uremic Toxicity: Present State of the Art
Vanholder, R., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., Dedeyn, P. P., Deppisch, R., Descamps-Latscha, B., Henle, T., et al. (2001) · The International Journal of Artificial Organs · doi:10.1177/039139880102401004 · Cited by 281
Self-citationStenvinkel, P., Wanner, C., Metzger, T., Heimbürger, O., Mallamaci, F., Tripepi, G., Malatino, L., & Zoccali, C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00637.x · Cited by 214
“4 mg/L whereas 45% of all patients had CRP levels>10 mg/L, which confirms that ESRD may be considered a chronic inflammatory stat”
BackgroundSelf-citationThe association of sudden cardiac death with inflammation and other traditional risk factors
Parekh, R. S., Plantinga, L. C., Kao, W. H. L., Meoni, L. A., Jaar, B. G., Fink, N. E., Powe, N. R., Coresh, J., & Klag, M. J. (2008) · Kidney International · doi:10.1038/ki.2008.449 · Cited by 181
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
van der Putten, K., Braam, B., Jie, K. E., & Gaillard, C. A. (2008) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0655 · Cited by 180
“Patients with CKD have increased levels of markers of inflammation such as C-reactive protein and the cytokines IL-1, IL-6, interferon (IFN)-γ and tumor necrosis factor (TNF)”
BackgroundStenvinkel, P. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_5.32 · Cited by 97
Self-citationRelevance of Oxidative Pathways in the Pathophysiology of Chronic Kidney Disease
Himmelfarb, J. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.005 · Cited by 81
Metadata
- Authors
- Stenvinkel, P.
- Venue
- Blood Purification
- Publisher
- S. Karger AG
- Published
- 2000-12-08
- Volume
- 19
- Issue
- 1
- Pages
- 53-61
- ISSN
- 0253-5068 (ISSN-L)
- 1421-9735
- OpenAlex
- W1972081368
- Cited by
- 207
- References
- 8
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.